Trump’s Vietnam Deal Shows China Tariffs Won’t Fall Much Further

Trump’s Vietnam Deal Shows China Tariffs Won’t Fall Much Further

(Bloomberg) — President Donald Trump’s new trade deal with Vietnam sends a clear signal about where US tariffs on Chinese goods might ultimately land, as talks between Washington and Beijing continue following their recent truce.

Most Read from Bloomberg

Chinese goods currently face tariffs of around 55%, a level expected to remain through August. But under the latest Vietnam agreement, the US will slap a 20% tariff on Vietnamese exports to the US and a steeper 40% levy on goods deemed to be transshipped — the latter targeting a well-worn backdoor used by Chinese exporters since the first China-US trade war to dodge American tariffs.

By closing the loopholes, the Trump administration is signaling what any future deal with China might look like. The 40% tariff on transshipped goods suggests that even if tariffs on China are eventually reduced, they’re unlikely to fall below that threshold.

“The 40% figure in the Vietnam deal might reflect a broader conviction in the Trump administration about the appropriate tariff level on China, which would be similarly reflected in other bilateral deals,” said Gabriel Wildau, a managing director at Teneo focused on political risk analysis in China. “However, I am skeptical that Trump has a specific red line for minimum tariffs on China.”

Beijing and Washington reached a trade framework last month following talks in London, which remains in effect through mid-August. As part of the deal, China agreed to resume shipments of rare earths — key inputs for wind turbines, electric vehicles and military hardware. In return, the US offered to ease some export restrictions on ethane, chip-design software and jet engine components.

US tariffs on Chinese goods have been cut back to around 55%, down from as high as 145% in early April. But 20% tariffs tied to fentanyl remain in place. Beijing has since tightened controls on two precursor chemicals used to make the drug — one of the few obvious avenues it has to win further tariff relief.

“The 20% is really the focal point where all the attention is centered right now,” said Christopher Beddor, deputy China research director at Gavekal Research. “The thinking is that the Chinese government is very willing to do a deal on something related to fentanyl. They’ve been telegraphing that months.”

Source link

Visited 1 times, 1 visit(s) today

Leave a Reply

Your email address will not be published. Required fields are marked *